Abstracts

This extension to the CONSORT Statement provides a minimum list of essential items, that authors should consider when reporting the main results of a randomized trial in any journal or conference abstract. Clear, transparent, and sufficiently detailed abstracts of conferences and journal articles are important, because readers often base their assessment of a trial on such information. Some readers use an abstract to decide whether to seek more information about a trial. However, in some parts of the world, readers often have access to the abstracts only, so health-care decisions may be made on the basis of abstracts of randomized trials. When a trial is reported at a conference, the abstract might provide the only permanent information accessible to most readers.

A collection of examples on using the CONSORT for Abstracts checklist has been provided as well.

Available Downloads

There is no flow diagram for this extension.

Document Word Format PDF Format
Statement Document n/a Download
Checklist Download Download
Explanation & Elaboration n/a Download

Reference

Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF and the CONSORT Group (2008) CONSORT for reporting randomised trials in journal and conference abstracts. Lancet: 371:281-283. PMID: 18221781

Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF and the CONSORT Group (2008) CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 5(1): e20. PMID: 18215107